Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Conditions:   Diphtheria;   Hepatitis B;   Haemophilus Influenzae Type b Disease;   Poliomyelitis;   Pertussis;   TetanusIntervention:   Biological: Infanrix hexa™Sponsors:   GlaxoSmithKline;   GlaxoSmithKlineCompleted - verified April 2013

Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials